FUTURE (Female Urgency, Trial of Urodynamics as Routine Evaluation) study has reached a milestone.
The trial team got in touch with us saying: “We have slightly exceeded our recruitment target of 1096 participants (with 1099 participants randomised) despite endless challenges due to COVID.” The trial is the largest of its kind and is being led by an Aberdeen team.
The FUTURE (Female Urgency, Trial of Urodynamics as Routine Evaluation) study is research study looking at how useful a special bladder test called ‘Urodynamics’ is at improving the treatment results for women affected by refractory overactive bladder (OAB). For more information please visit the FUTURE study website.
This project was funded by the National Institute for Health Research Health Technology Assessment (HTA) programme and is run by the University of Aberdeen, in conjunction NHS-Grampian. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of National Institute for Health Research, NHS Grampian or University of Aberdeen. Please visit each organisation's website for more information.